entertainment -WSS

entertainment

author：leisure time 2025-10-02 09:21:59 - browse：7983

An illustration of a human torso, through which the intestines, multicolored, are visible. — Adobe

We never walk alone. Across the landscape of our bodies, trillions of microbes accompany us on the journey of life, some of them riding it out in the body’s soft bits from first to dying breath.

A decade or so ago, the human microbiome was a revolutionary concept. Its unknown links to disease intrigued researchers across the globe. Now, some microbiome researchers are trying to usher in a new phase, in which modern tools and analytical approaches can show the connection between microbes and disease, and edge the field closer to potential treatments.

In the early days of this work, and still today, many findings were about correlations: a certain bug was found in a person with a specific illness. The effort now is to prove causation — which microbes could be directly responsible for the onset or progression of diseases. In the past week alone, three papers published in scientific journals have drawn links between microbiome residents and chronic diseases.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Elevance, private equity launch primary care company

Wikipedia

focus

WSS

Researchers on aging grapple with how to calculate biological age

Researchers on aging grapple with how to calculate biological age

Researchers on aging grapple with how to calculate biological age

After gene therapy, two congenitally deaf children hear for the first time

Making AI in medicine accessible to smaller, and rural hospitals

Elevance, private equity launch primary care company

knowledge

entertainment

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Study: Adult vaccinations pay for themselves in societal benefits

Drug repurposing or repositioning? The language matters

Study: AI not yet building 'n

Cancer drug shortages should be causing more outrage

The stability of $0 premiums in Medicare Advantage

Virginia high school admissions case could be legal follow

Apple Watch's A

Medicare details structure of new drug price negotiation program

Study: AI not yet building 'n

hotspot

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

CRISPR base editing slashes cholesterol levels in monkeys

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

H5N1 bird flu: what we're starting to learn about infection in cows

How to improve immunocompromised access to mAb treatments

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

entertainment

explore

focus

knowledge